Analystreport

Shuttle Pharmaceuticals (NASDAQ:SHPH) had its "sell (e)" rating reaffirmed by analysts at Weiss Ratings.

Shuttle Pharmaceuticals Holdings, Inc. - common stock  (SHPH)